Skip to content
PreclinicalImmuneSubQDaily for 10–20 daysPartial data

Chonluten

Glu-Asp-Gly · EDG

Khavinson bronchial/lung-derived tripeptide. Modulates monocyte/macrophage proliferation and downregulates adhesion molecules and IL-6.

§ 01   Overview

Overview

Khavinson bronchial/lung-derived tripeptide. Modulates monocyte/macrophage proliferation and downregulates adhesion molecules and IL-6.

Russian-lab publications.

§ 02   Mechanism

Mechanism of action

Chonluten (EDG) is proposed to modulate inflammation in bronchial epithelium by reducing adhesion molecule expression and IL-6 production in macrophages.

  • 01Anti-inflammatory in bronchial tissue models
  • 02Investigated for COPD

§ 03   Dosing

Dosing protocol

Standard Protocol

Dose Range
5 – 10 mg per course
Route
SubQ
Frequency
Daily for 10–20 days

§ 04   Evidence

Evidence & research

Preclinical

Russian-lab publications.

FDA Status

Not FDA-approved.

§ 06   News

In the news

8 articles from the last 12 months · updates hourly

§ 07   Sourcing

Sourcing & supply

Regulatory status

Authentic supply from international sources

Authentic product originates from specific international manufacturers, most commonly Russian pharmaceutical facilities for Khavinson bioregulators. RUO vendors selling the same name are typically Chinese-synthesized research vials, not the original product.

International · 2

International

Cosmic Nootropic

The most credible Russian / Khavinson source for US buyers. Sources authentic bioregulators through 'Peptides Company' (ex-NPCRIZ).

Visit
International

Rupharma

12+ year Russian pharmacy reseller. Reviews.io 4.84/5 (81+). Has a genuine US warehouse for common peptides.

Visit

Listings are informational, not endorsement. Verify credentials and flags against FDA and PCAB databases before purchasing. Full directory & how to verify →

§ 09   Safety

Safety & side effects

Side effects

  • 01Limited data

Contraindications

None specified.

§ 10   Questions

Chonluten FAQ

What is Chonluten?
Khavinson bronchial/lung-derived tripeptide. Modulates monocyte/macrophage proliferation and downregulates adhesion molecules and IL-6. Chonluten (EDG) is proposed to modulate inflammation in bronchial epithelium by reducing adhesion molecule expression and IL-6 production in macrophages.
What is Chonluten used for?
Reported uses include anti-inflammatory in bronchial tissue models and investigated for copd. Evidence strength is rated Preclinical — see the evidence section for detail.
How is Chonluten dosed?
Commonly referenced dosing is 5 – 10 mg per course, typically daily for 10–20 days, administered SubQ. This is educational reference only; consult a licensed clinician before use.
What are the side effects of Chonluten?
Commonly reported side effects include limited data. This list is not exhaustive.
Is Chonluten legal?
Authentic product originates from specific international manufacturers, most commonly Russian pharmaceutical facilities for Khavinson bioregulators. RUO vendors selling the same name are typically Chinese-synthesized research vials, not the original product. FDA status: Not FDA-approved..

§ 11   References

Selected references

  1. 01

    Int J Mol Sci 2022

    PMC8999041

This site is for educational and research purposes only. It does not constitute medical advice. Always consult a qualified healthcare provider before using any peptide or supplement.